Actimed secures extra £4.75M funding towards 'first globally approved product' treating cancer cachexia 22-Aug-2023 By Liza Laws Actimed Therapeutics Ltd will put some of its additional funding of £4.75 million ($6 million) towards its attempt to provide the world’s first cure for cancer cachexia.